Antitrust Laws and Generic Drug Competition: Protecting Patient Access
Explore how antitrust laws fight 'pay-for-delay' and product hopping to ensure generic drug competition and lower medication costs for patients.
Read DetailsTag: Hatch-Waxman Act
Federal Circuit Court: How It Controls Pharmaceutical Patent Cases in the U.S.
The Federal Circuit Court controls all U.S. pharmaceutical patent appeals, shaping when generics can launch, how patents are challenged, and ultimately, drug prices. Its rulings on ANDA jurisdiction, dosing patents, and standing have transformed the industry.
Read Details
